Hyperacute lung rejection in a pig-to-human transplant model: The role of anti-pig antibody and complement

Transplantation

Volumn 63, Issue 4, 1997, Pages 594-603

  Pierson III, Richard N ^a,b,d,e   Kasper Konig, Walter ^a,b,c   Tew, David N ^c   Young, Vincent K ^a,b,c   Dunning, John J ^a,b,c   Horsley, J O ^a,c   Carey, Nathaniel R B ^a,c   Wallwork, John ^a,b,c   White, David J G ^a,b,c  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b Imutran Ltd   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN M; PROPERDIN;

ADOLESCENT; ANIMAL MODEL; ARTICLE; BLOOD; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEAT SENSITIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LUNG INJURY; LUNG VASCULAR RESISTANCE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SWINE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES; COMPLEMENT SYSTEM PROTEINS; GRAFT REJECTION; HEAT; HUMANS; IMMUNOGLOBULIN M; LUNG TRANSPLANTATION; PERFUSION; SWINE; TRANSPLANTATION, HETEROLOGOUS; VASCULAR RESISTANCE;

EID: 0031041673     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199702270-00019     Document Type: Article

References (25)

1. Campbell GS, Crisp NW, Brown EB. Total cardiac bypass in humans utilizing a pump and heterologous lung oxygenator (dog lungs). Surgery 1956; 40: 364.
2. Waldhausen JA, Webb RC, Spencer FC, Bahnson HT. Study of the canine lung as an oxygenator of human and canine blood in extracorporeal circulation. Surgery 1957; 42: 726.
3. Bryant LR, Eiseman B, Avery M. Studies of the porcine lung as an oxygenator for human blood. J Thorac Cardiovasc Surg 1968; 55: 255.
4. Kaplon RJ, Platt JL, Kwiatkowski PA, et al. Absence of hyperacute rejection in pig-to-primate orthotopic pulmonary xenografts. Transplantation 1995; 59: 410.
5. Pace-Asciak C, Gryglewski R. The prostacyclins. In: Pace-Asciak C, Granstrom E, eds. Prostaglandins and related substances. New York: Elsevier, 1983: 3.
6. Mathieson PW, Qasim FJ, Thiru S, Oldroyd RG, Oliveira DB. Effects of decomplementation with cobra venom factor on experimental vasculitis. Clin Exp Immunol 1994; 97: 474.
7. Dunning JJ, Pierson RN III, Braidley PC, White DJG, Wallwork J. A comparison of the performance of pig hearts perfused with pig or human blood using an ex-vivo working heart model. Eur J Cardiothorac Surg 1994; 8: 204.
8. Halmagyi DFJ, Starzecki B, McRae J, Horner GJ. The lung as the main target organ in the acute phase of transfusion reaction in sheep. J Surg Res 1963; 3: 418.
9. 2 during incompatible homologous and heterologous blood transfusion in sheep [Abstract]. Anesthesiology 1988; 69: A122.
10. Cook WA, Klausner SK, Sinha S, Kikkawa Y, Veith FJ. A new look at hyperacute rejection. Am J Thorac Surg 1972; 13: 388.
11. Tavakoli R, Devaux JY, Nonnenmacher L, Louvel A, Weill B, Houssin D. Discordant lung xenograft rejection in the rat. Transplantation 1992; 53: 235.
12. Kusajima K, Wax SD, Webb WR, Aust JC. Cinemicroscopy of hyperacute pulmonary rejection. Am J Thor Surg 1976; 21: 341.
13. Kusajima K, Aust JC, Wax SD, Webb WR. Hemodynamic and functional changes in xenogenic, perfused, isolated lungs. J Thorac Cardiovasc Surg 1976; 72: 115.
14. Veith FJ, Richards KU, Hagstrom JWC, Montefusco CM. Intrafamilial lung xenografts from fox to dog. J Thorac Cardiovasc Surg 1981; 81: 546.
15. Speiller PB, Kikkawa Y, Veith FJ, Cook WA. Steroid protection of a pulmonary xenograft model. Surg Forum 1972; 23: 272.
16. Markman JF, Barker CF. Basic and clinical considerations in the use of xenografts. Curr Prob Surg 1994; 31: 385.
17. Shah AS, O'Hair DP, Kaplon RJ, et al. Absence of hyperacute rejection in pig-to-primate double lung xenografts. Oral presentation and abstract, ISHLT, San Francisco, CA, April 1995.
18. Fischel RJ, Dalmasso AP, Vercellotti GM, et al. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
19. Fukushima N, Bouchart F, Gundry SR, et al. The role of anti-pig antibody in pig-to-baboon cardiac xenotransplant rejection. Transplantation 1994; 57: 923.
20. Pruitt SK, Bollinger RR, Collins BH, et al. Continuous complement (C) inhibition using soluble C receptor Type 1 (sCR1): effect on hyperacute rejection of pig-to-primate cardiac xenografts. Transplant Proc 1996; 28: 756.
21. Kobayashi T, Taniguchi S, Ye Y, et al. Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor. Transplant Proc 1996; 28: 560.
22. Platt JL. Mechanisms of tissue injury in hyperacute xenogratt rejection. ASAIO J 1992; 38: 6.
23. Young VK, Pierson RN III, Kaspar-Konig W, Tew DN, Wallwork J, White DJG. White blood cells and platelets are integral to hyperacute rejection of the pig heart by human blood. Transplant Proc 1995; 27: 272.
24. Pierson RN III, Parker RE. Thromboxane mediates pulmonary vasoconstriction in pig lungs perfused with human blood. Transplant Proc 1996; 28: 635.
25. Robson SC, Young VK, Cook NS, et al. Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection. Transplantation 1996; 61: 862.